ENDO 2019 is jam-packed with sessions to keep you up-to-date with clinical and scientific advances in endocrinology; and thanks to the Endocrine Society’s Continuing Medical Education Services (CMES) and Special Programs Committee (SPC) there are even more opportunities to hear from the experts with Conference Events.
Conference Events are certified by the Endocrine Society and are planned and conducted under the supervision of the SPC in strict compliance with the Essential Standards & Guidelines of the Accreditation Council for Continuing Medical Education (ACCME).
There is no cost to attend and all ENDO 2019 attendees are welcome; however, seating is limited and advance registration is recommended. Complimentary breakfast or dinner will be provided. Tickets will not be issued this year, so arrive early as seating is done on a first-come, first-served basis. While available seating cannot be guaranteed, we will make every effort to accommodate you.
We have partnered with Lilly Diabetes to bring you an educational evening that will take you through the latest developments in diabetes care. As part of the program, you will engage with interactive stations, hear your colleagues' viewpoints on relevant topics impacting your clinical practice, and meet the dedicated Lilly Diabetes team. Food and refreshments will be provided for attendees. RSVP today.
Program Summary—Obesity is a complex disease that affects individuals differently with contributing factors well beyond lifestyle and environment. Among these factors, the role of genetics in obesity is often overlooked or misunderstood. In relatively recent years, the field of obesity medicine has uncovered genetic causes of obesity and developed novel treatments as emerging therapies. Although we are at the cusp of new options for rare causes of obesity, there are persistent challenges in awareness, screening, limited treatment options, and limited referral networks. This program will update clinicians on genetic causes of obesity and discuss how emerging treatments are shaping the landscape of options.
The Endocrine Society thanks Rhythm Pharmaceuticals for supporting this program.
Program Summary—Advances in continuous glucose monitoring (CGM) are changing glucose management from a largely reactionary approach to one that is predictive in nature. Flash glucose monitoring is part of this revolution. How we leverage these new tools in practice will depend of providers’ understanding of newer technology and their ability to effectively communicate practical guides to their patients. This program will update clinicians on how flash glucose monitoring is changing the landscape and how clinicians how put practical guides into action to make the most newer technologies.
The Endocrine Society thanks Abbott Diabetes Care for supporting this program.